Skip to main content
All lobbying clients

AMGEN INC

Lobbying client · District of Columbia · filed 2025 to 2026

$18,310,000 Reported spend
6 Filings counted
1 Firms hired
30 Bills named

Spend is reported income plus in-house expenses across 6 filings. 1 further filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the client's LDA id (103709), not by name.

 Firms hired 1
 Bills named in these filings 30
  • S 1040
    A bill to amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Vete…
    6 filings
  • HCONRES 14
    Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth…
    6 filings
  • HR 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…
    6 filings
  • HR 1672
    Maintaining Investments in New Innovation Act
    6 filings
  • S 1041
    Affordable Prescriptions for Patients Act
    6 filings
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
    5 filings
  • HR 1574
    RESTORE Patent Rights Act of 2025
    4 filings
  • HR 1968
    Full-Year Continuing Appropriations and Extensions Act, 2025
    4 filings
  • HR 2214
    DRUG Act
    4 filings
  • HR 3152
    Patent Eligibility Restoration Act of 2025
    4 filings
  • HR 3160
    PREVAIL Act
    4 filings
  • HR 5256
    340B ACCESS Act
    4 filings
  • HR 5526
    Biosimilar Red Tape Elimination Act
    4 filings
  • HR 946
    ORPHAN Cures Act
    4 filings
  • S 1546
    Patent Eligibility Restoration Act of 2025
    4 filings
  • S 1553
    PREVAIL Act
    4 filings
  • HR 3269
    ETHIC Act
    3 filings
  • HR 4317
    PBM Reform Act of 2025
    3 filings
  • HR 6166
    Lowering Drug Costs for American Families Act
    3 filings
  • HR 6485
    Skinny Labels, Big Savings Act
    3 filings
  • S 3019
    No Big Blockbuster Bailouts Act
    3 filings
  • S 3345
    PBM Price Transparency and Accountability Act
    3 filings
  • HR 1328
    Supply Chain Security and Growth Act of 2025
    2 filings
  • HR 4299
    Protecting Patient Access to Cancer and Complex Therapies Act
    2 filings
  • HR 4581
    340B PATIENTS Act of 2025
    2 filings
  • HR 5509
    Safe Step Act
    2 filings
  • HR 6624
    Biological Intellectual Property Protection Act of 2025
    2 filings
  • HR 7391
    Community Health Center Drug Pricing Protection Act
    2 filings
  • HR 7837
    Most Favored Patient Act of 2026
    2 filings
  • S 2296
    National Defense Authorization Act for Fiscal Year 2026
    2 filings
 Reported by year 2 years
  • 2026 $5,020,000 2 filings
  • 2025 $13,290,000 4 filings
 Issues lobbied 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 5
  • Centers For Medicare and Medicaid Services (CMS) 6
  • Health & Human Services, Dept of (HHS) 6
  • HOUSE OF REPRESENTATIVES 6
  • SENATE 6
  • Treasury, Dept of 5

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem